Vienna, Austria – Regulatory automation provider Platomics has announced a strategic pilot program with Agilent Technologies Inc. (NYSE: A) to enhance laboratory documentation capabilities for next-generation sequencing (NGS) tests under the European Union’s In Vitro Diagnostic Regulation (IVDR). This collaboration enables Agilent customers to leverage Platomics’ PlatoX® platform for generating comprehensive documentation required for IVDR […]
— Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced the founding of its Scientific Advisory Board (SAB), with key experts in diverse fields across biomanufacturing and advanced therapeutic development joining as inaugural members. The SAB will provide technical and strategic guidance for ongoing research and development programs and shape plans for […]
SAN JOSE, Calif. — In 2024, Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify its supply chain helping it to continue reliably serving customers with flexible, cost-effective next generation sequencing (NGS) solutions. Expanding U.S. manufacturing capabilities in 2024 and beyond After weathering a year of geopolitical […]
SAN DIEGO – Nucleus Biologics, a leader in precision cell culture media development, is proud to announce that it has achieved an industry-leading quality milestone. It has received EXCiPACT certification for Pharmaceutical Excipients and Pharmaceutical Auxiliary Materials (PAMs) and ISO 9001 certification from SGS. This Excipient GMP certification will better support the cell culture media, buffers, […]
ALAMEDA, Calif. — CellFE®, a leader in non-viral gene editing technology, and Syenex, a pioneer in enveloped delivery vectors, have announced an innovative collaboration to create a hybrid workflow that seamlessly integrates non-viral and viral approaches to cell therapy engineering. This next-generation process aims to enable streamlined workflows of complex edited cells for biotech and pharmaceutical […]
Dr Jose-Carlos Gutiérrez-Ramos is the Chief Science Officer at Danaher Corporation. He has held senior drug discovery roles at Pfizer, Abbvie, and GSK. As CEO and President of Synlogic, he led the company from early drug discovery to clinical stage and public markets He brings a wealth of experience across biotechs and pharmaceutical companies, combined with […]
World’s Most Comprehensive Protein Study Highlights Ultima’s Commitment to Unlocking the Power of Genomics at Scale FREMONT, Calif. — Ultima Genomics, Inc., a developer of an ultra-high throughput next-generation sequencing (NGS) platform, today announced that its UG 100™ was selected as the sequencing platform to enable UK Biobank’s unprecedented protein study, which will be the world’s largest […]
London, UK – LGC has today announced that Joydeep Goswami is joining its Board of Directors and Executive Leadership Team (ELT) as President and Chief Executive Officer (CEO). Joydeep succeeds Euan O’Sullivan, who decided to step down from his role in early 2024 after fourteen years of outstanding and dedicated service. Euan has worked closely with […]
ResolveSEQ MRD offers paired single cell genome and transcriptome characterization for discovering novel prognostic and therapeutic signatures in MRD cells New Certified Service Provider (CSP) Program will enable broader access to BioSkryb’s technology Durham, N.C. – BioSkryb Genomics, a pioneer in single-cell and ultra-low input multiomics is excited to announce the launch of ResolveSEQ MRD, an […]
ST. PAUL, Minn. — ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation, today announced that Seattle Children’s Therapeutics, a division of the Seattle Children’s Research Institute has been awarded a $125,000 G-Rex Grant. The G-Rex Grant will integrate state-of-the-art advancements into Seattle Children’s Therapeutics’ G-Rex based CAR-T cell platform. “This technology has been a […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
